Hosted on MSN1mon
Could lycopene—a plant extract—be an effective antidepressant?
Experiments indicated that a signaling pathway involving BDNF (called the BDNF-TrkB pathway, which helps regulate learning, memory, and communication between neurons) is inhibited in mice with ...
VITRAKVI Maintains Market Leadership Across the 7MM Amid Growing TRK Inhibitor Competition | DelveInsight
DelveInsight's "VITRAKVI Market Size, Forecast, and Market Insight Report" highlights the details around VITRAKVI, a TRK, TRKA, TRKB, and TRKC inhibitor. The report provides product descriptions, ...
Helsinki1y
Neuroplasticity and neurotrophic factors
The Trophin lab focuses on the role of neurotrophic factors, particularly Brain-Derived Neurotrophic Factor (BDNF) and its receptor TRKB, in plasticity of the adult brain and in the mechanisms of ...
DelveInsight Business Research, LLP: ROZLYTREK's Market Growth Reflects Transforming Treatment for NTRK and ROS1-Positive Cancers | DelveInsight
As biomarker testing and the demand for tumor-agnostic therapies rise, ROZLYTREK can potentially target a specialized yet valuable market segment. While competition from other TRK inhibitors ...
Helsinki4y
Neuroplasticity and neurotrophic factors
The Trophin lab focuses on the role of Brain-Derived Neurotrophic Factor (BDNF) and its receptor TRKB in the plasticity and in the mechanisms of drugs used for the treatment of brain disorders. We ...
DelveInsight Business Research, LLP: VITRAKVI Maintains Market Leadership Across the 7MM Amid Growing TRK Inhibitor Competition | DelveInsight
VITRAKVI has strong market potential as a first-in-class TRK inhibitor for patients with NTRK gene fusion-positive cancers, regardless of tumor type. The growing adoption of precision oncology ...